FTSE MIB
34.680,35 +341,03 (+0,99%) Dow Jones
39.387,76 +331,36 (+0,85%) Nasdaq
16.346,26 +43,46 (+0,27%) Nikkei 225
38.229,11 +155,13 (+0,41%) Petrolio
79,62 +0,36 (+0,45%) Bitcoin EUR
58.351,38 +1.773,41 (+3,13%)
Ovid Therapeutics Inc. (OVID)
Dopo ore:
| Chiusura precedente | 3,0900 |
| Aperto | 3,1000 |
| Denaro | 3,0400 x 200 |
| Lettera | 3,0700 x 400 |
| Min-Max giorno | 3,0050 - 3,1043 |
| Intervallo di 52 settimane | 2,5700 - 4,1390 |
| Volume | |
| Media Volume | 207.162 |
| Capitalizzazione | 215,973M |
| Beta (5 anni mensile) | 0,69 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,7400 |
| Prossima data utili | 10 mag 2024 - 11 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 7,69 |
GlobeNewswireOvid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit
NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure-related disorders, today announced that management will participate in a presentation at the Jefferies Inaugural Biotech CNS/Neuro Summit on Thursday, October 12, 2023, at 3:30 p.m. ET in New York. A live webcast of the Jefferies presentation can be accessed through the Events & Presentation
- GlobeNewswire
Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure-related disorders, today announced that it will host a Research & Development (R&D) Day investor event on Monday, October 2, 2023. The event will take place at the Company’s headquarters in New York’s Hudson Yards from 12:00 pm - 2:30 pm and will be webcast simultaneously. Ovid management w
- GlobeNewswire
Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure-related disorders, today announced that management will participate in a panel presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26, 2023, at 9:55 a.m. ET in New York, New York. A live webcast of the Cantor Fitzgerald presentation can be accessed
